Support for state legislation to allow terminally ill patients to use experimental drugs or treatments not yet fully approved for consumer use by the U.S. Food and Drug Administration was unanimously approved by the Board of Supervisors on a motion by Supervisor Michael D. Antonovich.
“Terminally ill patients should not have to navigate the FDA’s bureaucratic process to access a drug and treatment that may help save their life,” said Supervisor Antonovich.
As is allowed in a number of other states, terminally ill patients who have exhausted their options would only need their physician’s approval and a drug company willing to assist them, to pursue these potentially life-saving opportunities.
Add a comment
